Jbm (Healthcare) Ltd
HKEX:2161

Watchlist Manager
Jbm (Healthcare) Ltd Logo
Jbm (Healthcare) Ltd
HKEX:2161
Watchlist
Price: 2.71 HKD -0.37% Market Closed
Market Cap: 2.2B HKD

Relative Value

The Relative Value of one Jbm (Healthcare) Ltd stock under the Base Case scenario is hidden HKD. Compared to the current market price of 2.71 HKD, Jbm (Healthcare) Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Jbm (Healthcare) Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
9
vs Industry
50
Median 3Y
1.9
Median 5Y
1.6
Industry
2.6
Forward
2.6
vs History
44
vs Industry
39
Median 3Y
10.5
Median 5Y
10.2
Industry
21.7
Forward
9.1
vs History
19
vs Industry
46
Median 3Y
6.7
Median 5Y
6
Industry
16.6
vs History
36
vs Industry
32
Median 3Y
10.4
Median 5Y
8
Industry
22.5
vs History
9
vs Industry
47
Median 3Y
1
Median 5Y
1
Industry
2.3
vs History
9
vs Industry
51
Median 3Y
1.6
Median 5Y
1.5
Industry
2.9
Forward
2.3
vs History
16
vs Industry
52
Median 3Y
3.7
Median 5Y
3.4
Industry
5.5
vs History
51
vs Industry
40
Median 3Y
7.5
Median 5Y
7.3
Industry
13.1
Forward
5.9
vs History
44
vs Industry
43
Median 3Y
7.6
Median 5Y
7.6
Industry
16.6
Forward
7
vs History
19
vs Industry
47
Median 3Y
5.7
Median 5Y
5.6
Industry
15.8
vs History
19
vs Industry
36
Median 3Y
6.2
Median 5Y
6
Industry
19.1
vs History
9
vs Industry
52
Median 3Y
0.7
Median 5Y
0.7
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Jbm (Healthcare) Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
HK
Jbm (Healthcare) Ltd
HKEX:2161
2.2B HKD 2.8 11.2 7 8.6
US
Eli Lilly and Co
NYSE:LLY
939.9B USD 15.8 51 34.3 36.8
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
485.5B USD 5.3 19.3 15.8 20.5
CH
Roche Holding AG
SIX:ROG
252.8B CHF 4.1 26.8 11.5 13.4
UK
AstraZeneca PLC
LSE:AZN
210.6B GBP 4.8 29.9 108.2 158.3
CH
Novartis AG
SIX:NOVN
206B CHF 4.6 17.7 11.3 14.5
US
Merck & Co Inc
NYSE:MRK
239.1B USD 3.7 12.6 9 10.7
DK
Novo Nordisk A/S
CSE:NOVO B
1.3T DKK 4.2 12.8 8.9 10.4
IE
Endo International PLC
LSE:0Y5F
202.5B USD 87.3 -69.3 321.2 805.4
US
Pfizer Inc
NYSE:PFE
145.2B USD 2.3 14.8 7.5 10.3
P/E Multiple
Earnings Growth PEG
HK
Jbm (Healthcare) Ltd
HKEX:2161
Average P/E: 21.8
11.2
18%
0.6
US
Eli Lilly and Co
NYSE:LLY
51
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.3
29%
0.7
CH
Roche Holding AG
SIX:ROG
26.8
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
29.9
38%
0.8
CH
Novartis AG
SIX:NOVN
17.7
17%
1
US
Merck & Co Inc
NYSE:MRK
12.6
15%
0.8
DK
Novo Nordisk A/S
CSE:NOVO B
12.8
4%
3.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -69.3 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.8
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
HK
Jbm (Healthcare) Ltd
HKEX:2161
Average EV/EBITDA: 398.3
7
16%
0.4
US
Eli Lilly and Co
NYSE:LLY
34.3
33%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
15.8
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.5
4%
2.9
UK
AstraZeneca PLC
LSE:AZN
108.2
10%
10.8
CH
Novartis AG
SIX:NOVN
11.3
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9
6%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
8.9
2%
4.5
IE
E
Endo International PLC
LSE:0Y5F
321.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
1%
7.5
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
HK
Jbm (Healthcare) Ltd
HKEX:2161
Average EV/EBIT: 1 708.3
8.6
19%
0.5
US
Eli Lilly and Co
NYSE:LLY
36.8
36%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
20.5
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.4
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
158.3
23%
6.9
CH
Novartis AG
SIX:NOVN
14.5
12%
1.2
US
Merck & Co Inc
NYSE:MRK
10.7
8%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
10.4
1%
10.4
IE
E
Endo International PLC
LSE:0Y5F
805.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.3
8%
1.3